requirements for microalbuminuria are out of touch with the latest science
April 2012
Congratulations to PL editorial advisory board member, Dr. Craig Williams, PharmD, FNLA, BCPS, for his recent Pharmacotherapy editorial. It dispels the common belief that all diabetes patients with microalbuminuria need an ACE inhibitor or ARB, and complements our November 2012 article on the subject. Click here to view Dr. Williams' editorial.
Pay-for-performance requirements for microalbuminuria are out of touch with the latest science.Many want you to screen diabetes patients for proteinuria every year...and then TREAT microalbuminuria with an ACE inhibitor or ARB even if the patient doesn't have hypertension.
The idea is to slow the progression of kidney disease.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote